590 participants
A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-12-01
- Start Date:
- 2005-06-30
- Completion:
- 2006-09-30
Conditions
- Rheumatoid Arthritis
Interventions
- DRUG
No Results Yet